ABC 11 Raleigh, NC on MSN
Duke Eye Center pioneers new gene therapy for rare eye disease, MacTel
Duke Eye Center has become the first academic medical center in the country to implant a new cell-based gene therapy for a rare eye disease called MacTel. This procedure offers hope to patients like ...
ZEVASKYN ® (prademagene zamikeracel) is an autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis ...
Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.
Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only ...
TipRanks on MSN
Abeona Therapeutics announces permanent J-Code for ZEVASKYN
Abeona Therapeutics (ABEO) announced that the Centers for Medicare and Medicaid Services has established a permanent Healthcare Common Procedure ...
In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...
Medpage Today on MSN
ATTR Trial's Safety Freeze; Heart Failure After Twins; Sotatercept Approval Expands
As alternatives to intravascular lithotripsy, cutting balloon angioplasty and super-high-pressure non-compliant balloons were noninferior in the Short-CUT and VICTORY trials, as highlighted by the ...
Scientists are on the brink of even preventing some diseases — not just treating them — at the sperm, egg and early embryo ...
A large clinical trial shows stem cell therapy can help repair heart tissue and improve recovery in patients after a heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results